Follicular thyroid cancer and Hürthle cell carcinoma: challenges in diagnosis, treatment, and clinical management (Q50163635)

26 February 2018

http://europepmc.org/abstract/MED/29102432

title

Follicular thyroid cancer and Hürthle cell carcinoma: challenges in diagnosis, treatment, and clinical management (English)

1 reference

26 February 2018

http://europepmc.org/abstract/MED/29102432

main subject

follicular thyroid cancer

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29102432%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Cosimo Durante

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29102432%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

author name string

Livia Lamartina

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29102432%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Sebastiano Filetti

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29102432%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

David S Cooper

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29102432%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

publication date

25 October 2017

1 reference

26 February 2018

http://europepmc.org/abstract/MED/29102432

published in

The Lancet: Diabetes & Endocrinology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29102432%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29102432%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29102432%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

page(s)

500-514

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29102432%20AND%20SRC:MED&resulttype=core&format=json

Current thyroid cancer trends in the United States

7 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Genomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Descriptive epidemiology of thyroid carcinoma in Carinthia, Austria: 1984-2001. Histopathologic features and tumor classification of 734 cases under elevated general iodination of table salt since 1990: population-based age-stratified analysis on th

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

The changing incidence of thyroid carcinoma in Shenyang, China before and after universal salt iodization

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Changing trends of incidence and prognosis of thyroid carcinoma in lower Franconia, Germany, from 1981-1995

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Follicular thyroid cancer incidence patterns in the United States, 1980-2009

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Changing trends in incidence and mortality of thyroid cancer in Scotland

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

The History of the Follicular Variant of Papillary Thyroid Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Diagnostic changes as a reason for the increase in papillary thyroid cancer incidence in Geneva, Switzerland

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Follicular Thyroid Carcinoma: How Have Histologic Diagnoses Changed in the Last Half-Century and What Are the Prognostic Implications?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Iodine deficiency a persisting problem: assessment of iodine nutrition and evaluation of thyroid nodular pathology in Portugal.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Iodine deficiency and thyroid nodular pathology--epidemiological and cancer characteristics in different populations: Portugal and South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Time trends for thyroid cancer in northwestern Spain: true rise in the incidence of micro and larger forms of papillary thyroid carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Thyroid cancer, thyroiditis and dietary iodine: a review based on the Salta, Argentina model

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

A clinicopathologic study of minimally invasive follicular carcinoma of the thyroid gland with a review of the English literature.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

A Val 677 activating mutation of the thyrotropin receptor in a Hürthle cell thyroid carcinoma associated with thyrotoxicosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

A Phe 486 thyrotropin receptor mutation in an autonomously functioning follicular carcinoma that was causing hyperthyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Follicular thyroid carcinoma: histology and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

A Bedside Risk Calculator to Preoperatively Distinguish Follicular Thyroid Carcinoma from Follicular Variant of Papillary Thyroid Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Comparison of clinical characteristics at diagnosis and during follow-up in 118 patients with Hurthle cell or follicular thyroid cancer

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Reassessing the NTCTCS Staging Systems for Differentiated Thyroid Cancer, Including Age at Diagnosis.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Prognosis and prognostic factors for distant metastases and tumor mortality in follicular thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Risk factors for lateral cervical lymph node involvement in follicular thyroid carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Association of vascular invasion with increased mortality in patients with minimally invasive follicular thyroid carcinoma but not widely invasive follicular thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Clinicopathological and molecular histochemical review of skull base metastasis from differentiated thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Patterns of metastasis in follicular thyroid carcinoma and the difference between early and delayed presentation

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Comparison of survival rates between papillary and follicular thyroid carcinomas among 36,725 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Age and tumor size predicts lymph node involvement in Hürthle Cell Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Follicular thyroid carcinoma in an iodine-replete endemic goiter region: a prospectively collected, retrospectively analyzed clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Follicular thyroid carcinoma: differences in clinical relevance between minimally invasive and widely invasive tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Clinical and molecular features of Hürthle cell carcinoma of the thyroid

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Hürthle cell carcinoma of the thyroid: Retrospective review of 62 patients treated at the Royal Marsden Hospital between 1946 and 2003.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Patients with follicular and Hurthle cell microcarcinomas have compromised survival: a population level study of 22,738 patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Histological patterns of locoregional recurrence in Hürthle cell carcinoma of the thyroid gland

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Tumor protrusion with intensive blood signals on ultrasonography is a strongly suggestive finding of follicular thyroid carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Subcategorization of Bethesda System Category III by Ultrasonography

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Management of thyroid follicular proliferation: an ultrasound-based malignancy score to opt for surgical or conservative treatment

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Thyroid follicular carcinoma: sonographic features of 50 cases

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Preoperative serum thyroglobulin as a useful predictive marker to differentiate follicular thyroid cancer from benign nodules in indeterminate nodules

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Sonographic features of thyroid follicular carcinoma in comparison with thyroid follicular adenoma

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Well-Differentiated Thyroid Cancer: The Philippine General Hospital Experience

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Differential diagnostic ultrasound criteria of papillary and follicular carcinomas: a multivariate analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Evaluating the degree of conformity of papillary carcinoma and follicular carcinoma to the reported ultrasonographic findings of malignant thyroid tumor

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Shear-Wave Elastography for the Preoperative Risk Stratification of Follicular-patterned Lesions of the Thyroid: Diagnostic Accuracy and Optimal Measurement Plane.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Is elastography actually useful in the presurgical selection of thyroid nodules with indeterminate cytology?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Acoustic radiation force impulse imaging (ARFI) for differentiation of benign and malignant thyroid nodules--A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Could 18F-FDG-PET/CT avoid unnecessary thyroidectomies in patients with cytological diagnosis of follicular neoplasm?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Examining the Role of Preoperative Positron Emission Tomography/Computerized Tomography in Combination with Ultrasonography in Discriminating Benign from Malignant Cytologically Indeterminate Thyroid Nodules

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ASSOCIAZIONE MEDICI ENDOCRINOLOGI MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR THE DIAGNOSIS AND MANAGEMENT OF THYROID NODULES--2016 UPDATE.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Ultrasonography Diagnosis and Imaging-Based Management of Thyroid Nodules: Revised Korean Society of Thyroid Radiology Consensus Statement and Recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

ACR Thyroid Imaging, Reporting and Data System (TI-RADS): White Paper of the ACR TI-RADS Committee

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Korean Thyroid Imaging Reporting and Data System features of follicular thyroid adenoma and carcinoma: a single-center study.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Predictive factors of malignancy in patients with cytologically suspicious for Hurthle cell neoplasm of thyroid nodules

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Tumor size predicts malignant potential in Hürthle cell neoplasms of the thyroid

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): A changing paradigm in thyroid surgical pathology and implications for thyroid cytopathology.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

The Bethesda System For Reporting Thyroid Cytopathology

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Yield of repeat fine-needle aspiration biopsy and rate of malignancy in patients with atypia or follicular lesion of undetermined significance: the impact of the Bethesda System for Reporting Thyroid Cytopathology

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Routine second-opinion cytopathology review of thyroid fine needle aspiration biopsies reduces diagnostic thyroidectomy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Bethesda Categorization of Thyroid Nodule Cytology and Prediction of Thyroid Cancer Type and Prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Prevalence and prediction of malignancy in cytologically indeterminate thyroid nodules

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Thyroid cytology and risk of thyroid cancer: differences among indeterminate specimens

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Risk of malignancy in follicular neoplasms without nuclear atypia: statistical analysis of 397 thyroidectomies.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

The meaning and predictivity of Hürthle cells in fine needle aspiration cytology for thyroid nodular disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Hürthle cell carcinoma is a better gold standard than Hürthle cell neoplasm for fine-needle aspiration of the thyroid: defining more consistent and specific cytologic criteria

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Fine-needle aspiration of Hürthle cell lesions. A cytomorphologic approach to diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

The cytologic category of oncocytic (Hurthle) cell neoplasm mostly includes low-risk lesions at histology: an institutional experience.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Molecular differences between human thyroid follicular adenoma and carcinoma revealed by analysis of a murine model of thyroid cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Molecular pathogenesis and mechanisms of thyroid cancer

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Risk stratification of indeterminate thyroid fine-needle aspiration biopsy specimens based on mutation analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing assay.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Evaluation of ThyroSeq v2 performance in thyroid nodules with indeterminate cytology

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Preoperative diagnosis of benign thyroid nodules with indeterminate cytology

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Multicenter clinical experience with the Afirma gene expression classifier.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Clinical Factors Influencing the Performance of Gene Expression Classifier Testing in Indeterminate Thyroid Nodules

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Molecular Testing for miRNA, mRNA, and DNA on Fine-Needle Aspiration Improves the Preoperative Diagnosis of Thyroid Nodules With Indeterminate Cytology

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Update to the College of American Pathologists reporting on thyroid carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Interobserver and intraobserver reproducibility in the histopathology of follicular thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Prognostic factors of minimally invasive follicular thyroid carcinoma: extensive vascular invasion significantly affects patient prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Distant metastasis at diagnosis and large tumor size are significant prognostic factors of widely invasive follicular thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Risk Factors for Distant Metastasis in Patients with Minimally Invasive Follicular Thyroid Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Prognostic Impact of Further Treatments on Distant Metastasis in Patients With Minimally Invasive Follicular Thyroid Carcinoma: Verification Using Inverse Probability of Treatment Weighting.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

The total number of tissue blocks per centimetre of tumor significantly correlated with the risk of distant metastasis in patients with minimally invasive follicular thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Histology does not influence prognosis in differentiated thyroid carcinoma when accounting for age, tumour diameter, invasive growth and metastases

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Primary tumour diameter as a risk factor for advanced disease features of differentiated thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Long-term follow-up after complete resection of well-differentiated cancer confined to the thyroid gland

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Prognostic factors determining survival in differentiated thyroid cancer

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Prognostic factors of papillary and follicular thyroid cancer: differences in an iodine-replete endemic goiter region

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Differentiated thyroid cancer presenting with distant metastases: a population analysis over two decades

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Frequency of TERT promoter mutations in human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Staging systems for follicular thyroid carcinoma: application to 171 consecutive patients treated in a tertiary referral centre.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Follicular thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Follicular thyroid carcinoma: the role of histology and staging systems in predicting survival

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Application of staging systems for differentiated thyroid carcinoma in an endemic goiter region with iodine substitution

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Follicular Thyroid Carcinoma: Disease Response Evaluation Using American Thyroid Association Risk Assessment Guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Does completion thyroidectomy improve the outcome of patients with minimally invasive follicular carcinoma of the thyroid?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Can minimally invasive follicular thyroid cancer be approached as a benign lesion?: a population-level analysis of survival among 1,200 patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Operative strategy for follicular thyroid cancer in risk groups stratified by pTNM staging

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Survival and prognostic factors for survival, cancer specific survival and disease free interval in 239 patients with Hurthle cell carcinoma: a single center experience

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Prevalence of cancer in follicular thyroid nodules: is there still a role for intraoperative frozen section analysis?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

The value of frozen section in intraoperative surgical management of thyroid follicular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Cost effectiveness of intraoperative pathology examination during diagnostic hemithyroidectomy for unilateral follicular thyroid neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Radioactive Iodine Treatment Is Associated with Improved Survival for Patients with Hürthle Cell Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Outcomes and prognostic factors of 251 patients with minimally invasive follicular thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Radioactive iodine offers survival improvement in patients with follicular carcinoma of the thyroid

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Follicular thyroid carcinoma: prognostic factors and the role of radioiodine

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Prognostic factors for disease-specific survival in 108 patients with Hürthle cell thyroid carcinoma: a single-institution experience

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

No survival difference after successful (131)I ablation between patients with initially low-risk and high-risk differentiated thyroid cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Minimally invasive follicular thyroid carcinomas: prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Long-Term Outcome of Follicular Thyroid Carcinoma in Patients Undergoing Surgical Intervention for Skeletal Metastases

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Prognostic indices for tumor relapse and tumor mortality in follicular thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Is there a role for radiation therapy in the management of Hürthle cell carcinoma?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Emerging strategies for managing differentiated thyroid cancers refractory to radioiodine

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Lenvatinib versus placebo in radioiodine-refractory thyroid cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Follicular and Hurthle cell carcinoma of the thyroid in iodine-sufficient area: retrospective analysis of Korean multicenter data

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Importance of lymph node metastases in follicular thyroid cancer

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Diagnosis, treatment, and outcome of follicular thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Prognostic significance of patient age in minimally and widely invasive follicular thyroid carcinoma: investigation of three age groups.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Prognostic factors of recurrence in encapsulated Hurthle cell carcinoma of the thyroid gland: a clinicopathologic study of 50 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Differentiated thyroid carcinoma: defining new paradigms for postoperative management.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

ENDOCRINE TUMOURS: Imaging in the follow-up of differentiated thyroid cancer: current evidence and future perspectives for a risk-adapted approach

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

Follicular thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2817%2930325-X

7 January 2021

10.1016/S2213-8587(17)30325-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29102432%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

1 reference